Henlius Expands in MENAT with SVAX Partnership
Deal News | Nov 07, 2024 | Fosun Capital Group
Henlius, a renowned biopharmaceutical company under Fosun Capital Group, has entered into a strategic partnership with Saudi Arabia's SVAX (AL-TIRYAQ AL-KHALAWI Medical Company) during the 7th China International Import Expo. This collaboration will see joint ventures established in Saudi Arabia, combining Henlius' expertise in biologics research and development with SVAX's regional prowess in registration and commercialization. The partnership aims to promote Henlius' products across the Middle East, North Africa, and Türkiye (MENAT), such as biosimilars HANDAYUAN, HANBEITAI, and investigational HLX17. With both companies focusing on innovative and affordable therapies, they seek to improve healthcare access and affordability in the region, aligned with the MENAT market's fast-evolving biopharmaceutical landscape, propelled by governmental support and growing healthcare demands.
Sectors
- Biopharmaceuticals
- Healthcare
- Venture Capital/Private Equity
Geography
- Saudi Arabia – The joint ventures between Henlius and SVAX will be established here, serving as a launchpad for their MENAT regional strategy.
- MENAT – The Middle East, North Africa, and Türkiye are the target regions for the distribution and commercialization of Henlius' biopharmaceutical products through SVAX.
- China – Henlius is based in China, from where it spearheads its global biopharmaceutical innovations and strategies.
Industry
- Biopharmaceuticals – The industry involves the research, development, and manufacturing of biologic medicines, which is the core focus of Henlius and SVAX in their strategic partnership.
- Healthcare – The healthcare industry encompasses services and products aimed at promoting health, including the biologic medications that Henlius and SVAX aim to deliver in the MENAT region.
- Venture Capital/Private Equity – This sector is relevant as Fosun Capital Group, a private equity firm, supports Henlius, facilitating strategic partnerships and investments in new markets.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Henlius | Biopharmaceutical Company | Company | A global biopharmaceutical company focused on developing innovative, affordable biologic medicines for oncology, autoimmune, and ophthalmic diseases. |
| SVAX | Local Partner in Biologics Commercialization | Company | A Saudi company focused on localizing biomanufacturing and ensuring the supply of vaccines and biologics in the MENAT region. |
| Fosun Capital Group | Private Equity Firm | Company | The PE firm associated with Henlius, supporting its strategic expansions and partnerships. |
| Fakeeh Family | Owner of SVAX | People | A prominent family group in Saudi Arabia known for their contributions to the healthcare sector. |